Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock, $0.00001 par value per share
-
Shares outstanding
-
54,965,124
-
Total 13F shares
-
12,538,172
-
Share change
-
+358,238
-
Total reported value
-
$16,299,458
-
Price per share
-
$1.30
-
Number of holders
-
57
-
Value change
-
+$393,906
-
Number of buys
-
29
-
Number of sells
-
43
Institutional Holders of Akoya Biosciences, Inc. - Common Stock, $0.00001 par value per share (AKYA) as of Q2 2025
As of 30 Jun 2025,
Akoya Biosciences, Inc. - Common Stock, $0.00001 par value per share (AKYA) was held by
57 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
12,538,172 shares.
The largest 10 holders included
Blue Water Life Science Advisors, LP, ODDO BHF ASSET MANAGEMENT SAS, VANGUARD GROUP INC, PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE, Trium Capital LLP, BlackRock, Inc., GEODE CAPITAL MANAGEMENT, LLC, PEDDOCK CAPITAL ADVISORS, LLC, ExodusPoint Capital Management, LP, and JANE STREET GROUP, LLC.
This page lists
57
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.